• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

特发性红细胞增多症患者中JAK2 V617F突变的发生率。

The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis.

作者信息

Percy Melanie J, Jones Frank G C, Green Anthony R, Reilly John T, McMullin Mary Frances

出版信息

Haematologica. 2006 Mar;91(3):413-4. Epub 2006 Feb 17.

PMID:16503548
Abstract

Sixty-three patients with erythrocytosis exhibiting a range of erythropoietin levels were screened for the JAK2 V617F mutation. One patient (1.6%) was found to have this mutation, and has remained stable for 9 years, suggesting that the JAK2 V617F mutation is rare in patients with idiopathic erythrocytosis.

摘要

对63例红细胞增多症患者进行了促红细胞生成素水平测定，并筛查了JAK2 V617F突变。发现1例患者（1.6%）存在该突变，且9年来病情一直稳定，提示JAK2 V617F突变在特发性红细胞增多症患者中较为罕见。

相似文献

1
The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis.特发性红细胞增多症患者中JAK2 V617F突变的发生率。
Haematologica. 2006 Mar;91(3):413-4. Epub 2006 Feb 17.
2
A gain-of-function mutation of JAK2 in myeloproliferative disorders.骨髓增殖性疾病中JAK2的功能获得性突变。
N Engl J Med. 2005 Apr 28;352(17):1779-90. doi: 10.1056/NEJMoa051113.
3
The effect of the JAK2 V617F mutation on PRV-1 expression.JAK2 V617F突变对PRV-1表达的影响。
Haematologica. 2006 Mar;91(3):411-2. Epub 2006 Feb 17.
4
The JAK2 V617F mutation is absent in patients with erythrocytosis due to high oxygen affinity hemoglobin variants.由于高氧亲和力血红蛋白变异体导致的红细胞增多症患者不存在JAK2 V617F突变。
Hemoglobin. 2006;30(4):487-9. doi: 10.1080/03630260600868147.
5
Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis.检测JAK2 V617F作为红细胞增多症的首要诊断试验。
Leukemia. 2006 Feb;20(2):350-3. doi: 10.1038/sj.leu.2404069.
6
Polycythemia vera: scientific advances and current practice.真性红细胞增多症：科学进展与当前实践
Semin Hematol. 2005 Oct;42(4):206-20. doi: 10.1053/j.seminhematol.2005.08.003.
7
Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis.真性红细胞增多症继发布加综合征患者血清促红细胞生成素水平升高：JAK2突变分析作用的临床意义
Eur J Haematol. 2006 Jul;77(1):57-60. doi: 10.1111/j.1600-0609.2006.00667.x.
8
A longitudinal study of the JAK2(V617F) mutation in myelofibrosis with myeloid metaplasia: analysis at two time points.骨髓化生伴骨髓纤维化中JAK2（V617F）突变的纵向研究：两个时间点的分析
Haematologica. 2006 Mar;91(3):415-6.
9
[Acquired mutation of JAK2 tyrosine kinase and polycythaemia vera].
Ann Biol Clin (Paris). 2006 Jan-Feb;64(1):3-9.
10
The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates.伴有髓外化生的骨髓纤维化中的JAK2（V617F）酪氨酸激酶突变：谱系特异性及临床相关性
Br J Haematol. 2005 Nov;131(3):320-8. doi: 10.1111/j.1365-2141.2005.05776.x.

引用本文的文献

1
Dissecting Primary Erythrocytosis Among Polycythemia Patients Referred to an Indian Armed Forces Hospital.剖析转诊至一家印度武装部队医院的红细胞增多症患者中的原发性红细胞增多症
Indian J Hematol Blood Transfus. 2020 Jan;36(1):187-191. doi: 10.1007/s12288-019-01155-0. Epub 2019 Jul 8.
2
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study.低JAK2V617F等位基因负荷在临床实践中的相关性：一项单中心研究。
Oncotarget. 2017 Jun 6;8(23):37239-37249. doi: 10.18632/oncotarget.16744.
3
Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations.
基因 panel 测序改善了特发性红细胞增多症患者的诊断检查，并鉴定出了新的突变。
Haematologica. 2016 Nov;101(11):1306-1318. doi: 10.3324/haematol.2016.144063. Epub 2016 Sep 20.
4
Clinical utility gene card for: familial erythrocytosis.家族性红细胞增多症临床应用基因卡
Eur J Hum Genet. 2012 May;20(5). doi: 10.1038/ejhg.2011.252. Epub 2012 Jan 25.
5
JAK2 V617F mutation is rare in idiopathic erythrocytosis: a difference from polycythemia vera.JAK2 V617F突变在特发性红细胞增多症中罕见：与真性红细胞增多症的差异。
Int J Hematol. 2008 Jul;88(1):82-87. doi: 10.1007/s12185-008-0103-6. Epub 2008 Jun 6.
6
Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis.JAK2 V617F阴性真性红细胞增多症、红细胞增多症和原发性骨髓纤维化中的表型变异与新突变。
Exp Hematol. 2007 Nov;35(11):1641-6. doi: 10.1016/j.exphem.2007.08.010. Epub 2007 Oct 17.
7
A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.一种新的与红细胞增多症相关的PHD2突变提示了低氧诱导因子结合凹槽的位置。
Blood. 2007 Sep 15;110(6):2193-6. doi: 10.1182/blood-2007-04-084434. Epub 2007 Jun 19.
8
JAK2 V617F: a single mutation in the myeloproliferative group of disorders.JAK2 V617F：骨髓增殖性疾病组中的单一突变。
Ulster Med J. 2006 May;75(2):112-9.
9
Oxygen sensing: recent insights from idiopathic erythrocytosis.氧感应：来自特发性红细胞增多症的最新见解
Cell Cycle. 2006 May;5(9):941-5. doi: 10.4161/cc.5.9.2723. Epub 2006 May 1.